JUPITER NEUROSCIENCES, INC. Prepaid Expense and Other Assets, Current
JUPITER NEUROSCIENCES, INC. (JUNS) had Prepaid Expense and Other Assets, Current of $114.09 thousand as of 2024-12-31, per its 10-K filed 2025-03-28.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2025-03-28
- 2024-12-31: Prepaid Expense and Other Assets, Current $114.09K.
- 2023-12-31: Prepaid Expense and Other Assets, Current $261.00.
| Period end | Prepaid Expense and Other Assets, Current |
|---|---|
| 2024-12-31 | $114.09K 10-K · filed 2025-03-28 |
| 2023-12-31 | $261.00 10-K · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |